学校主站

抓质量,上水平,创特色

Pay attention to quality, improve level and create characteristics

师资队伍

赵秀举

来源: 时间:2026年07月01日 00:00 编辑: 点击:

姓名:赵秀举

政治面貌:群众

所在系 / 教研室:生技系

导师资格:研究生导师

职称/职务:教授

电子邮箱 QQ :422184256(兼邮箱、关联微信)

主讲课程:生物化学、生物化学实验、中药生物技术、基因工程实验、生物统计学、数据处理软件综合应用、R语言实验、高级生物统计学

个人简介

博士,教授,研究生导师。发表Briefings in Bioinformatics综述(2022年小类排一)等论文79篇、它引3万余次,临床医学ESI(基本科学指标)千分之五首要贡献者和学科带头人、高被引论文10篇、其中5篇热点、它引2.2万余次,参与3件发明专利、主导1件人白血病数据处理发明专利公开。结题和在研国家基金学科建设与研究生培养研究专项重点项目等25个。


教育经历

2008/06-2012/03,中国科学院武汉物理与数学研究所,分析化学(核磁共振与代谢组学),博士,导师:王玉兰研究员和唐惠儒研究员

2005/09-2007/07,武汉大学,生物物理学,硕士,导师:谭铮教授

1999/09-2003/07,陕西科技大学,生物工程,学士


工作 / 访学经历

2017/08-2018/08, Texas A&M University, Department of Nutrition and Food Science,访问学者,合作导师 Chaodong Wu

2012/04-至今,武汉轻工大学,生物与制药工程/生命科学与技术学院,讲师、副教授、教授

2007/07-2008/02,国家高新技术企业武汉佳成技术中心副主任


主要研究方向

生物学、统计学、教育学,

发育健康营养、多模态智能化、学科专业建设。


主持代表性科研项目

生命及关联学科基于常态化监测的“双一流”建设成效评价研究(国家社科基金学科建设与研究生培养研究专项重点项目,ZSA250509),35万

啮齿动物对乙酰甲喹的代谢组应答(973课题 2009CB118804),200806-201112,参加,450万

非酒精性脂肪肝病发生发展及饮食干预机制(湖北省自然科学基金面上项目 2012FFB04802),201301-201412,1/6,3万

中链脂肪酸-肝肠因子轴与抗炎功能(湖北省教育厅科学技术研究计划重点项目D20191603),1/6,4万

人白血病转录组预测因素检测和发现技术(技术秘密普通许可,长沙杰瑞生物科技有限公司,合同登记编号2024420601002488),95万


主持代表性教研项目

深度学习导向下数据处理软件综合应用多维度教学探索与实践(武汉轻工大学教研项目面上XM2024012),0.8万,2024至2025


代表性学术论文

1.代谢组NMR分析与药物毒理研究.波谱学杂志, 2011, 28 (1), 1-17. 1st & Correspondence.

2.Dynamic metabolic response of mice to acute mequindox exposure. Journal of Proteome Research, 2011, 10, 5183-5190. 1st. 乙酰甲喹

3.Systems responses of rats to mequindox revealed by metabolic and transcriptomic profiling. Journal of Proteome Research, 2012, 11, 4712-4721. 1st. 乙酰甲喹

4.ECR-MAPK regulation in liver early development. BioMed Research International,2014: 850802. 1st & Correspondence. 个体早期发育

5.Intervention of pumpkin seed oil on metabolic disease revealed by metabonomics and transcript profile. Journal of the Science of Food and Agriculture, 2017, 97(4): 1158-1163. 1st & Correspondence. 南瓜

6.Dynamic Lipid Profile of Hyperlipidemia Mice. Journal of Chromatography B, 2017, 1055–1056: 165–171. Correspondence.

7.Risk Factors and Biomarkers of Non-alcoholic Fatty Liver Disease: an observational cross-sectional population survey. BMJ open. 2018;8:e019974. Correspondence. 以中国中部地区1479人横断面观察型临床试验为对象,运用代谢组检测、多变量Logistic回归和接受者操作特征曲线下面积(AUROC),发现非酒精性脂肪肝病(NAFLD)新的高发年龄段50-60岁和新的危险因素与生物标志物油酸羟化油酸酯。

8.Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2018; 392: 1995–2051. Coauthor.

9.Prediction of cause-specific disability-adjusted life-years in China 2018-2021: a systematic analysis. Public Health. 2020,180:90-99. Correspondence. 伤残调整寿命年

10.Global, regional, and national burden of cirrhosis by aetiology in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology 2020;5(3):245-266. Coauthor.

11.NMR-based plasma metabonomics in Hyperlipidemia Mice. Analytical Methods 2020, 12, 1995 - 2001. Correspondence.候选封面

12.Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. Nature Medicine 2020, 26: 750–759. coauthor

13.Mapping geographic inequalities in childhood diarrhoeal morbidity and mortality in low- and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017. The Lancet 2020, 395(10239):1779-1801. Coauthor.

14.Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17. The Lancet Global Health 2020, 8(8):e1038-e1060. Coauthor. 口服补液疗法

15.Five insights from the Global Burden of Disease Study 2019. Lancet 2020; 396: 1135–1159.

16.Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396(10258):1223-1249.

17.Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet 2020; 396(10258):1250-1284.

18.Local Burden of Disease Vaccine Coverage Collaborators. Mapping routine measles vaccination in low- and middle-income countries. Nature, 2021; 589: 415–419 麻疹

19.Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet 2021 Sep 4;398(10303):870-905.

20.Intervention of 4% salmon phospholipid on metabolic syndrome in mice based on colonic lipidomics analysis. Journal of the Science of Food and Agriculture, 102 (8), 3088-3098 (2022).

21.Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ-British Medical Journal. 2022 Mar 10;376:e068208.

22.Linking research of biomedical datasets. Briefings in Bioinformatics 2022, 23 (6): bbac373. DOI: 10.1093/bib/bbac373. Review. 数学与计算生物学 1/57。1st & Correspondence. 提出生物数据学(biodatatics),概括其类脑生态理论,即全流程数据活动机制DCSAE(多样兼顾,环节衔接,安全共享,权责一致,生态使能)多样化弱关联数据集通过原生类脑方式(动力引擎和思想知识双轮驱动,算法和算力协调匹配)预测发现。数据环节,概括为设计、采样、预处理与分析和治理,通过技术导则、标准化、应用程序接口、软件开发包、模型参数等衔接。匿名化和去标识化,对抗训练,群体学习,高性能图计算,图查询语言,混合事务分析处理等,兼顾深度计算、海量存储和高并发通讯,实现数据安全共享。以比例原则分配不同数据参与方的权利与义务、权力与职责。数据在使用中升值,不同数据参与方都能从中获益,形成数据生态系统(物料平衡、能量守恒、简单优先)。

23.Dietary interventions of salmon and silver carp phospholipids on mice with metabolic syndrome based on lipidomics. Cells, 2022, 11, 3199.

24.可扩展普适性指导下的生物统计学本科教学。教育科学(引文版),2023(6):25-27

25.Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024, 403 (10440): 2162-2203.

26.Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. 2024, 403 (10440): 2204-2256.

27.Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nature Communications May 7 2025, 16(1):4235.


指导学生项目及获奖

[1] 国家三等奖,生命科学竞赛,科学探究类,2026 年,晏江婷,等;指导教师(排 1)

[2] 湖北省三等奖,生命科学竞赛,科学探究类,2025 年,胡秀立,等;指导教师(排 1)


学术兼职与社会服务

期刊相关: Journal of Cell Science, International Journal of Obesity, Bioscience Reports, Analytical Methods, European Journal of Epidemiology等SCI 期刊长期审稿人

专家库:湖北省自然科学奖复评专家、科技项目评审专家

湖北省首批中小微企业“科技副总”(2020,武汉腾高信息技术有限公司)。


学术会议报告

(分会报告 / 大会主旨 / 主持论坛)

1.2019 4月19日,第一届中国生物物理学会代谢组学分会年会暨 2019 代谢组学国际研讨会Risk factors and biomarkers of non-alcoholic fatty liver disease 上海(speech)分会口头报告

2.2021 9月29日,第二届中国生物物理学会代谢组学分会年会暨 2021 代谢组学国际研讨会Knowledge- & Data-driven: Lipidomics, Statistical learning 上海(speech)分会口头报告和分会主持

3.2022 9月23日,Knowledge- & Data-driven: Metabonomics, Machine learning第一届中国生物安全信息学高峰论坛 武汉(speech)特邀报告